Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

A Phase 2 Study of Luspatercept in Patients with Myelofibrosis-Associated Anemia

Blood (2019) 134 (Supplement_1): 557.

https://doi.org/10.1182/blood-2019-122546

Published: 2019

Journal Articles

Luspatercept Significantly Reduces Red Blood Cell (RBC) Transfusion Burden, Regardless of Gene Mutation Frequency, Spectrum, and Prognostic Significance, Among Patients (Pts) with LR-MDS Enrolled in the MEDALIST Trial

Blood (2019) 134 (Supplement_1): 2999.

https://doi.org/10.1182/blood-2019-123655

Published: 2019

Journal Articles

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

John Koreth, Haesook T. Kim, Kyle T. Jones, Paulina B. Lange, Carol G. Reynolds, Marie J. Chammas, Katherine Dusenbury, Jennifer Whangbo, Sarah Nikiforow, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Yi-Bin Chen, David Avigan, Bruce R. Blazar, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer

Blood (2016) 128 (1): 130–137.

https://doi.org/10.1182/blood-2016-02-702852

Published: 2016

Includes: Supplemental data

Journal Articles

Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD

Ana C. Alho, Haesook T. Kim, Marie J. Chammas, Carol G. Reynolds, Tiago R. Matos, Edouard Forcade, Jennifer Whangbo, Sarah Nikiforow, Corey S. Cutler, John Koreth, Vincent T. Ho, Philippe Armand, Joseph H. Antin, Edwin P. Alyea, Joao F. Lacerda, Robert J. Soiffer, Jerome Ritz

Blood (2016) 127 (5): 646–657.

https://doi.org/10.1182/blood-2015-10-672345

Published: 2016

Includes: Supplemental data

Journal Articles

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Masahiro Hirakawa, MD PhD, Tiago R Matos, MD MSc, Edouard Forcade, MD, Kathy S. Wang, PhD, Eduardo L Espada, MD, Jennifer Whangbo, MD PhD, Carol G Reynolds, PhD, Marie J Chammas, Kazuyuki Murase, MD PhD, Jerome Ritz, MD

Blood (2015) 126 (23): 3425.

https://doi.org/10.1182/blood.V126.23.3425.3425

Published: 2015

Journal Articles

Long-Term Homeostatic Effects of Daily Low-Dose IL-2 on CD4+ FoxP3+ Regulatory T Cells in Patients with Active Chronic Graft-Versus-Host Disease

Jennifer Whangbo, MD PhD, John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Katharine Dusenbury, Ana Cristina Alho, MD, Carol G Reynolds, PhD, Marie J Chammas, Kyle T Jones, Sarah Nikiforow, MD PhD, Corey S Cutler, MD MPH, Vincent T. Ho, MD, Philippe Armand, MD PhD, Edwin P. Alyea, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD

Blood (2015) 126 (23): 3133.

https://doi.org/10.1182/blood.V126.23.3133.3133

Published: 2015

Journal Articles

Homeostatic Reconstitution of CD4+ Regulatory and Conventional T Cell Subsets in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Ana Cristina Alho, MD, Kim T Haesook, PhD, Carol G Reynolds, PhD, Marie J Chammas, BSc, Sean McDonough, MS, Suzan Lazo-Kallanian, John Daley, PhD, Sarah Nikiforow, MD PhD, Corey S Cutler, MD MPH, John Koreth, MBBS, DPhil, Vincent T Ho, MD, Philippe Armand, MD PhD, Robert J. Soiffer, MD, Joseph H Antin, MD, Jerome Ritz, MD

Blood (2014) 124 (21): 2496.

https://doi.org/10.1182/blood.V124.21.2496.2496

Published: 2014

Journal Articles

Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Phase 2 and Long Term Efficacy, Safety and Immune Correlates

John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Kyle T. Jones, BSc, Carol G Reynolds, PhD, Marie J Chammas, BSc, Katherine Dusenbury, BSc, Jennifer Whangbo, MD PhD, Sarah Nikiforow, MD PhD, Edwin P. Alyea, MD, Philippe Armand, MD PhD, Corey S Cutler, MD MPH, Vincent T Ho, MD, Yi-Bin Chen, MD, David Avigan, MD, Joseph H Antin, MD, Jerome Ritz, MD, Robert J Soiffer, MD

Blood (2014) 124 (21): 41.

https://doi.org/10.1182/blood.V124.21.41.41

Published: 2014

Journal Articles

Differential Plasma Cytokine Levels in Patients with and without Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Caron A. Jacobson, MD, Joshua Geary, Haesook T Kim, PhD, Sean McDonough, MS, Carol G Reynolds, PhD, Maria I. Herrera, MD, PhD, John Koreth, MBBS, DPhil, Corey Cutler, MD, MPH, FRCPC, Vincent T Ho, MD, Edwin P Alyea, III, MD, Philippe Armand, MD, PhD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD

Blood (2012) 120 (21): 4476.

https://doi.org/10.1182/blood.V120.21.4476.4476

Published: 2012

Journal Articles

Patterns of B Cell Activating Factor (BAFF) Levels, B Cell Recovery, and BAFF/B Cell Ratios Correlate with the Development of Chronic Graft-Versus-Host Disease (cGVHD) Following Hematopoietic Stem Cell Transplantation (HSCT)

Caron A. Jacobson, MD, Haesook T Kim, PhD, Stefanie Sarantopoulos, MD, PhD, Lixian Sun, MS, Sean McDonough, MS, Carol G Reynolds, PhD, Maria I. Herrera, MD, PhD, John Koreth, MBBS, DPhil, Corey S. Cutler, MD, MPH, FRCPC, Vincent T Ho, MD, Edwin P Alyea, III, MD, Philippe Armand, MD, PhD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD

Blood (2011) 118 (21): 3036.

https://doi.org/10.1182/blood.V118.21.3036.3036

Published: 2011

Journal Articles

Improved Immune Reconstitution After Bortezomib-Based Acute Graft-Versus-Host Disease Prophylaxis for HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Allogeneic Transplantation.

John Koreth, MBBS, DPhil, Kristen E. Stevenson, MS, Haesook T. Kim, PhD, Sean McDonough, Maria I. Herrera, PhD, Carol G. Reynolds, Gorka Murga, Vincent T. Ho, MD, Corey Cutler, MD, MPH, Philippe Armand, MD, PhD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Edwin P. Alyea, III, MD, Jerome Ritz, MD

Blood (2009) 114 (22): 48.

https://doi.org/10.1182/blood.V114.22.48.48

Published: 2009

Journal Articles

Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis

Mignon L. Loh, Shashaank Vattikuti, Suzanne Schubbert, Melissa G. Reynolds, Elaine Carlson, Kenneth H. Lieuw, Jennifer W. Cheng, Connie M. Lee, David Stokoe, Jeannette M. Bonifas, Nicole P. Curtiss, Jason Gotlib, Soheil Meshinchi, Michelle M. Le Beau, Peter D. Emanuel, Kevin M. Shannon

Blood (2004) 103 (6): 2325–2331.

https://doi.org/10.1182/blood-2003-09-3287

Published: 2004

Journal Articles

Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease

FA Grasser, PG Murray, E Kremmer, K Klein, K Remberger, W Feiden, G Reynolds, G Niedobitek, LS Young, N Mueller-Lantzsch

Blood (1994) 84 (11): 3792–3798.

https://doi.org/10.1182/blood.V84.11.3792.bloodjournal84113792

Published: 1994

NARROW

A Phase 2 Study of Luspatercept in Patients with Myelofibrosis-Associated Anemia

Luspatercept Significantly Reduces Red Blood Cell (RBC) Transfusion Burden, Regardless of Gene Mutation Frequency, Spectrum, and Prognostic Significance, Among Patients (Pts) with LR-MDS Enrolled in the MEDALIST Trial

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Long-Term Homeostatic Effects of Daily Low-Dose IL-2 on CD4+ FoxP3+ Regulatory T Cells in Patients with Active Chronic Graft-Versus-Host Disease

Homeostatic Reconstitution of CD4+ Regulatory and Conventional T Cell Subsets in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Phase 2 and Long Term Efficacy, Safety and Immune Correlates

Differential Plasma Cytokine Levels in Patients with and without Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Patterns of B Cell Activating Factor (BAFF) Levels, B Cell Recovery, and BAFF/B Cell Ratios Correlate with the Development of Chronic Graft-Versus-Host Disease (cGVHD) Following Hematopoietic Stem Cell Transplantation (HSCT)

Improved Immune Reconstitution After Bortezomib-Based Acute Graft-Versus-Host Disease Prophylaxis for HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Allogeneic Transplantation.

Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis

Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only